BioSpace News Archive

Advanced Glycation End Products Market Classified on the basis of Type, Application, and End User – Global Industry Analysis

The increasing cases of cancer are prognosticated to help boost the global advanced glycation end products market growth during the forecast period 2020 to 2030.

April 14, 2022
·
5 min read
Global Methadone Hydrochloride Market: New Development | Growth Opportunity | Upcoming Trends and Players in the Industry – Analysis Report [2020-2030]

Methadone, a synthetic narcotic analgesic, is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine.

April 14, 2022
·
5 min read
Protein Labelling Market: The cell-based assays segment is anticipated to expand at a rapid CAGR during the forecast period

Albany NY, United States: In biological research procedures, there is frequent utilization of molecular labels that are linked to a protein of interest in order to assist in the detection as well as purification of the labeled protein along with its binding partners.

April 14, 2022
·
6 min read
Pressure Bandages Market: Global Demand, Growth Opportunities and Market Segmentation Analysis [2030]

The rising incidence of venous leg ulcers has emerged as a serious clinical problem worldwide, draining substantial financial resources.

April 14, 2022
·
7 min read
Pigmented Lesion Treatment Market: Growing geriatric population across the world to drive the market

Albany NY, United States: Pigmented lesion is a kind of skin disease, wherein black, brown, or blue lesions appear on the skin.

April 14, 2022
·
7 min read
Needle-Free Injectors Market is Set to Experience a Significant Growth of 11.9% CAGR From 2021 To 2031 - Comprehensive Research Report By FMI

DUBAI, United Arab Emirates, According to a latest study by Future Market Insights, global needle-free injectors sales are expected to reach US$ 12.3 Bn in 2021, surging at 11.9% CAGR during the forecast period.

April 14, 2022
·
6 min read
Drug Development

Press Release: Positive Phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Positive results from the Phase 1/2 dose-finding study evaluating the safety, pharmacokinetics and clinical activity of rilzabrutinib, an investigational oral Bruton’s tyrosine kinase inhibitor, in adults with heavily pre-treated immune thrombocytopenia were published in the New England Journal of Medicine.

April 14, 2022
·
8 min read
Business

Inotrem and the Crohn’s & Colitis Foundation Sign a R&D Collaboration Agreement to Support the Development of a New Therapeutic Approach in Inflammatory Bowel Disease (IBD)

Inotrem announced a R&D collaboration agreement with the Crohn’s & Colitis Foundation to support the development of a new therapeutic approach in IBD.

April 14, 2022
·
3 min read
Bio NC

Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age

Pfizer Inc. and BioNTech SE announced positive results from a Phase 2/3 clinical trial evaluating the safety, tolerability and immunogenicity of a 10-µg booster dose of the Pfizer-BioNTech COVID-19 vaccine in healthy children 5 through 11 years of age.

April 14, 2022
·
23 min read
Policy

Valneva Receives Conditional Marketing Authorization from UK MHRA for its Inactivated COVID-19 Vaccine

Valneva SE announced that the Medicines and Healthcare products Regulatory Agency of the United Kingdom has granted Conditional Marketing Authorization for its inactivated whole-virus COVID-19 vaccine candidate, VLA2001, for primary immunization in adults 18 to 50 years of age.

April 14, 2022
·
5 min read